↓ Skip to main content

rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion

Overview of attention for article published in Molecular Therapy, January 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

patent
13 patents

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion
Published in
Molecular Therapy, January 2006
DOI 10.1016/j.ymthe.2005.12.002
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 3 4%
Unknown 77 96%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 24 30%
Researcher 13 16%
Student > Bachelor 7 9%
Student > Master 7 9%
Other 4 5%
Other 8 10%
Unknown 17 21%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 24 30%
Biochemistry, Genetics and Molecular Biology 20 25%
Neuroscience 3 4%
Chemical Engineering 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 9 11%
Unknown 20 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2026.
All research outputs
#3,799,086
of 25,374,917 outputs
Outputs from Molecular Therapy
#1,352
of 4,917 outputs
Outputs of similar age
#13,030
of 170,775 outputs
Outputs of similar age from Molecular Therapy
#8
of 44 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,917 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.2. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,775 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.